Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMART Design for Prednisone Tapering in Rheumatoid Arthritis
NCT06072768Phase 2Recruiting
- Sponsor
- VA Office of Research & Development
- Start
- Mar 2023
- Primary completion
- Mar 2029
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of prednisone in rheumatoid arthritis (RA), sponsored by VA Office of Research & Development. Started Mar 2023; status: recruiting.
02
Drugs
prednisone
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT06072768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06072768.